Experience

Celcuity

• United States
• Biotechnology
• 1 - 100 Employee

• Senior Principal Investigator

  • Aug 2023 - Present

  Minneapolis, Minnesota, United States Celcuity is a diagnostic and pharmaceutical company that has developed a unique diagnostic test based on functional activity in signaling pathways of patient-derived cancer cells to stratify patients that should respond to cancer therapeutics. Identify new combination therapies with Gedatolisib, a potential first-in-class dual pan-PI3K and mTOR inhibitor in clinical trials. Leading R&D to optimize growth conditions and develop cellular stress assays in primary cancer cells.

• Principal Investigator

  • Jul 2019 - Aug 2023

  Minneapolis, Minnesota Celcuity is a diagnostic and pharmaceutical company that has developed a unique diagnostic test based on functional activity in signaling pathways of patient-derived cancer cells to stratify patients that should respond to cancer therapeutics. Identify new combination therapies with Gedatolisib, a potential first-in-class dual pan-PI3K and mTOR inhibitor in clinical trials. Leading R&D to optimize growth conditions and develop cellular stress assays in primary cancer cells.



University of California, San Francisco

• United States
• Higher Education
• 700 & Above Employee

• Assistant Professor In Residence

  • Feb 2012 - Jul 2019

  San Francisco, California Worked as PI and Assistant Professor leading research programs including new target discovery focusing on treatment-resistant cells, cancer stem cells, and persister cells in patient-derived tumor cultures followed by proof-of-concept and pre-clinical efficacy in vivo studies, including genetically-engineered and patient-derived cancer models.

• Assistant Adjunct Professor

  • Aug 2008 - Feb 2012

  Brain Tumor Research

• Postdoctoral Fellow

  • Feb 2005 - Jul 2008

  Brain Tumor Research



Sahlgrenska University Hospital

• Sweden
• Hospitals and Health Care
• 700 & Above Employee

• Postdoctoral Fellow

  • Nov 2003 - Jan 2005

  Brain Tumor Research